0001938657-24-000001.txt : 20240301 0001938657-24-000001.hdr.sgml : 20240301 20240301165056 ACCESSION NUMBER: 0001938657-24-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240301 DATE AS OF CHANGE: 20240301 EFFECTIVENESS DATE: 20240301 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RYNE Biotechnology Inc. CENTRAL INDEX KEY: 0001938657 ORGANIZATION NAME: IRS NUMBER: 880611114 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-506550 FILM NUMBER: 24710864 BUSINESS ADDRESS: STREET 1: ONE BROADWAY STREET 2: 14TH FLOOR KENDALL SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 815-505-6466 MAIL ADDRESS: STREET 1: ONE BROADWAY STREET 2: 14TH FLOOR KENDALL SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02142 D 1 primary_doc.xml X0708 D LIVE 0001938657 RYNE Biotechnology Inc. ONE BROADWAY 14TH FLOOR KENDALL SQUARE CAMBRIDGE MA MASSACHUSETTS 02142 815-505-6466 DELAWARE None None Corporation true 2022 Jonathan Yeh One Broadway 14th Floor Kendall Square Cambridge MA MASSACHUSETTS 02142 Director Howard Federoff One Broadway 14th Floor Kendall Square Cambridge MA MASSACHUSETTS 02142 Executive Officer Director Nick Manusos One Broadway 14th Floor Kendall Square Cambridge MA MASSACHUSETTS 02142 Executive Officer Director Peter Fuhrken One Broadway 14th Floor Kendall Square Cambridge MA MASSACHUSETTS 02142 Director Martin Ostrowski One Broadway 14th Floor Kendall Square Cambridge MA MASSACHUSETTS 02142 Executive Officer David Fallace One Broadway 14th Floor Kendall Square Cambridge MA MASSACHUSETTS 02142 Director Jeff Jonas One Broadway 14th Floor Kendall Square Cambridge MA MASSACHUSETTS 02142 Director Jeff Goater One Broadway 14th Floor Kendall Square Cambridge MA MASSACHUSETTS 02142 Director Biotechnology Decline to Disclose 06b false 2024-02-26 false true true false 0 81832753 30000000 51832753 A portion of the Total Offering Amount and Total Amount Sold was comprised of the cancellation and conversion of certain indebtedness or other conversion instrument previously issued by the Company. false 9 0 0 0 false RYNE Biotechnology Inc. /s/ Nick Manusos Nick Manusos CEO 2024-03-01